CANCER RES 润色咨询

CANCER RESEARCH

出版年份:1941 年文章数:12632 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:2.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2022-10-28 嘻嘻哈哈623

    请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2023-07-13 ms9000000602781212 来自北京

    请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2023-07-13 ms9000000602781212 来自北京

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:蛋白质翻译后修饰;肿瘤
    经验分享:请问大家proof结束后多久能有排好版的文章上线啊?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2018-06-16 小小小蹄子

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:第一稿,小修:
    Stage Start Date
    Waiting for Revision 2018-05-01 11:24:14
    Decision Sent to Author 2018-05-01 11:24:14
    Under Review 2018-04-30 17:54:03
    Decision Pending 2018-04-30 17:53:41
    Under Review 2018-04-02 16:34:31
    Under Editorial Consideration 2018-04-02 15:53:37
    Initial QC 2018-04-02 10:23:42
    Manuscript Submission 2018-04-02 04:57:41
    第二稿,格式修改:
    编辑给重新写了摘要,改了标题。
    Waiting for Revision 2018-06-08 13:31:15
    Decision Sent to Author 2018-06-08 13:31:15
    Under Review 2018-06-05 20:21:13
    Decision Pending 2018-06-05 20:20:58
    Under Review 2018-05-23 10:44:35
    Under Editorial Consideration 2018-05-23 04:33:34
    Manuscript Submission 2018-05-21 22:28:24
    第三稿,接受:
    Stage Start Date
    Manuscript Ready for Publication 2018-06-15 11:20:47
    Decision Sent to Author 2018-06-15 11:20:47
    Under Review 2018-06-15 11:20:22
    Decision Pending 2018-06-15 11:20:22
    Under Review 2018-06-15 11:20:22
    Under Editorial Consideration 2018-06-11 04:36:15
    Manuscript Submission 2018-06-10 01:37:25
    这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。
    希望后面的兄弟姐妹好运。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2021-07-21 1582019d51m

    请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2022-09-19 ms5000001982894673

    偏重的研究方向:肿瘤
    经验分享:各位大神,CR送外审不会发邮件通知么?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2022-05-24 杨明月字九州

    各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2021-01-12 1215c911m91暂无昵称

    投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2020-03-11 doctor杨

    二审提交后staff会先审格式,格式合格之后就直接under review了zyg1 2020-03-10 发表::
    老哥,二审一般多久under review啊
    zyg1 2020-03-10 00:00:00 发表:
    老哥,二审一般多久under review啊

    zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀?感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家,文章proof回去之后多久能更新啊?网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147876, encodeId=9bf2214e8765b, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:蛋白质翻译后修饰;肿瘤<br>经验分享:请问大家proof结束后多久能有排好版的文章上线啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:32:28 CST 2023, time=2023-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=558040, encodeId=d91b55804092, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一稿,小修: <br> Stage Start Date <br> Waiting for Revision 2018-05-01 11:24:14 <br> Decision Sent to Author 2018-05-01 11:24:14 <br> Under Review 2018-04-30 17:54:03 <br> Decision Pending 2018-04-30 17:53:41 <br> Under Review 2018-04-02 16:34:31 <br> Under Editorial Consideration 2018-04-02 15:53:37 <br> Initial QC 2018-04-02 10:23:42 <br> Manuscript Submission 2018-04-02 04:57:41 <br> 第二稿,格式修改: <br> 编辑给重新写了摘要,改了标题。 <br> Waiting for Revision 2018-06-08 13:31:15 <br> Decision Sent to Author 2018-06-08 13:31:15 <br> Under Review 2018-06-05 20:21:13 <br> Decision Pending 2018-06-05 20:20:58 <br> Under Review 2018-05-23 10:44:35 <br> Under Editorial Consideration 2018-05-23 04:33:34 <br> Manuscript Submission 2018-05-21 22:28:24 <br> 第三稿,接受: <br> Stage Start Date <br> Manuscript Ready for Publication 2018-06-15 11:20:47 <br> Decision Sent to Author 2018-06-15 11:20:47 <br> Under Review 2018-06-15 11:20:22 <br> Decision Pending 2018-06-15 11:20:22 <br> Under Review 2018-06-15 11:20:22 <br> Under Editorial Consideration 2018-06-11 04:36:15 <br> Manuscript Submission 2018-06-10 01:37:25 <br> 这个投稿系统附件图片不支持tiff,整到PDF里面分辨率又太低,来来回回跟编辑拉扯了好几次。感觉我们想法不重要,按他们说的来就好了。 <br> 希望后面的兄弟姐妹好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=742, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/04/5badf8a0248e81ed1f762a35444fa1de.jpg, createdBy=f1192053852, createdName=小小小蹄子, createdTime=Sat Jun 16 09:18:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001382, encodeId=1e39100138251, content=请问状态变成under review指送外审了吗?但是没有收到送审的邮件通知呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ddd92153968, createdName=1582019d51m, createdTime=Wed Jul 21 13:09:03 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向:肿瘤<br>经验分享:各位大神,CR送外审不会发邮件通知么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬,我的状态under review不到一天,就变成了decision pending,是什么情况呢?被拒的概率有多大?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇,几天就拒稿了。内容数据创新都比里边文章不差,感觉越来越难,越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式,格式合格之后就直接under review了<span class="quote">zyg1 2020-03-10 发表::<br>老哥,二审一般多久under review啊</span><span class="quote">zyg1 2020-03-10 00:00:00 发表:<br>老哥,二审一般多久under review啊</span>, beContent=zyg1 2020-03-10 发表:: 老哥,二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿,大修 <br> <br> Stage Start Date <br> Revision Received 2018-10-30 <br> Revision Abandoned 2018-10-01 <br> Waiting for Revision 2018-05-29 <br> Decision Sent to Author 2018-05-29 <br> Under Review 2018-05-26 <br> Decision Pending 2018-05-26 <br> Under Review 2018-04-23 <br> Under Editorial Consideration 2018-04-23 <br> Initial QC 2018-04-22 <br> Manuscript Submission 2018-04-22 <br> 第二稿,小修 <br> <br> Stage Start Date <br> Revision Received 2018-12-08 <br> Waiting for Revision 2018-12-06 <br> Decision Sent to Author 2018-12-06 <br> Under Review 2018-12-05 <br> Decision Pending 2018-12-05 <br> Under Review 2018-11-14 <br> Under Editorial Consideration 2018-10-30 <br> Manuscript Submission 2018-10-30 <br> 第三稿,格式修改 <br> Stage Start Date <br> Revision Received 2019-01-14 <br> Waiting for Revision 2019-01-14 <br> Decision Sent to Author 2019-01-14 <br> Under Review 2019-01-10 <br> Decision Pending 2019-01-10 <br> Under Review 2018-12-21 <br> Under Editorial Consideration 2018-12-10 <br> Manuscript Submission 2018-12-08 <br> 第四稿,接收 <br> Stage Start Date <br> Manuscript Ready for Publication 2019-02-01 <br> Decision Sent to Author 2019-02-01 <br> Under Review 2019-02-01 <br> Decision Pending 2019-02-01 <br> Under Review 2019-02-01 <br> Under Editorial Consideration 2019-01-14 <br> Manuscript Submission 2019-01-14 <br> 开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2019-02-02 1252364am52(暂无昵称)

    第一稿,大修

    Stage Start Date
    Revision Received 2018-10-30
    Revision Abandoned 2018-10-01
    Waiting for Revision 2018-05-29
    Decision Sent to Author 2018-05-29
    Under Review 2018-05-26
    Decision Pending 2018-05-26
    Under Review 2018-04-23
    Under Editorial Consideration 2018-04-23
    Initial QC 2018-04-22
    Manuscript Submission 2018-04-22
    第二稿,小修

    Stage Start Date
    Revision Received 2018-12-08
    Waiting for Revision 2018-12-06
    Decision Sent to Author 2018-12-06
    Under Review 2018-12-05
    Decision Pending 2018-12-05
    Under Review 2018-11-14
    Under Editorial Consideration 2018-10-30
    Manuscript Submission 2018-10-30
    第三稿,格式修改
    Stage Start Date
    Revision Received 2019-01-14
    Waiting for Revision 2019-01-14
    Decision Sent to Author 2019-01-14
    Under Review 2019-01-10
    Decision Pending 2019-01-10
    Under Review 2018-12-21
    Under Editorial Consideration 2018-12-10
    Manuscript Submission 2018-12-08
    第四稿,接收
    Stage Start Date
    Manuscript Ready for Publication 2019-02-01
    Decision Sent to Author 2019-02-01
    Under Review 2019-02-01
    Decision Pending 2019-02-01
    Under Review 2019-02-01
    Under Editorial Consideration 2019-01-14
    Manuscript Submission 2019-01-14
    开始对格式要求较低,此后越来越高,费时费力,从业十年来,最辛苦的文章,比更高档次的杂志都繁琐。

    1

    展开1条回复
共372条页码: 3/38页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分